Cargando…
State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy
Specific delivery of therapeutic agents to solid tumors and their bioavailability at the target site are the most clinically important and challenging goals in cancer therapy. Liposomes are promising nanocarriers and have been well investigated for cancer therapy. In spite of preferred accumulation...
Autores principales: | Heidarli, Elmira, Dadashzadeh, Simin, Haeri, Azadeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843293/ https://www.ncbi.nlm.nih.gov/pubmed/29552041 |
Ejemplares similares
-
Preparation, In-Vitro Characterization and Pharmacokinetic Evaluation of Brij Decorated Doxorubicin Liposomes as a Potential Nanocarrier for Cancer Therapy
por: Fazel, Mohammadtaghi, et al.
Publicado: (2018) -
Combined Approach of Ligand Targeted and Stimuli-triggered Nanocarriers: a State-of-the-art Strategy for Cancer Treatment
por: Haeri, Azadeh
Publicado: (2017) -
Doxorubicin-Loaded Multivesicular Liposomes (DepoFoam) as a Sustained Release Carrier Intended for Locoregional Delivery in Cancer Treatment: Development, Characterization, and Cytotoxicity Evaluation
por: Mahjoub, Mohammad Ali, et al.
Publicado: (2023) -
Preparation and Characterization of Stable Nanoliposomal Formulation of Fluoxetine as a Potential Adjuvant Therapy for Drug-Resistant Tumors
por: Haeri, Azadeh, et al.
Publicado: (2014) -
A Simple and Sensitive HPLC Method for Fluorescence Quantitation of Doxorubicin in Micro-volume Plasma: Applications to Pharmacokinetic Studies in Rats
por: Daeihamed, Marjan, et al.
Publicado: (2015)